Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $115.3000 (-1.03%) ($114.8300 - $116.9300) on Thu. Feb. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.94% (three month average) | RSI | 57 | Latest Price | $115.3000(-1.03%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(43%) IBB(42%) XBI(41%) VFMO(39%) VT(39%) | Factors Impacting UTHR price | UTHR will decline at least -0.97% in a week (0% probabilities). VXX(-13%) TLT(-13%) VIXM(-10%) UUP(-10%) XHB(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.97% (StdDev 1.94%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
Resistance Level | $115.33 | 5 Day Moving Average | $116.29(-0.85%) | 10 Day Moving Average | $116.13(-0.71%) | 20 Day Moving Average | $115.33(-0.03%) | To recent high | -5.1% | To recent low | 13.7% | Market Cap | $5.114b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |